Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of ESOP'.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has allotted 38,774 equity shares of Rs. 2 each to eligible employees under its Employee Stock Option Plan 2022, after they exercised their vested options. The exercise prices were Rs. 94 for 14,500 shares, Rs. 113.6 for 11,210 shares, and Rs. 115.6 for 13,064 shares. As a result, the company's paid-up share capital has gone up modestly from Rs. 13.30 crore to Rs. 13.31 crore, with total shares rising from 6.65 crore to about 6.66 crore. The newly issued shares carry no lock-in and rank equally with existing shares.
This is a routine ESOP allotment with no material dilution impact for existing shareholders. The increase in share count is tiny (under 0.06%) and unlikely to affect the stock price.